| Application number | Title of the application | Filing Date | Status |
|---|
| 09/543188 | Prion-binding ligands and methods of using same | Apr 4, 2000 | Abandoned |
| 09/509612 | HEPATITIS C RECEPTOR PROTEIN CD81 | Mar 28, 2000 | Abandoned |
Array
(
[id] => 880483
[patent_doc_number] => 07355015
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2008-04-08
[patent_title] => 'Matriptase, a serine protease and its applications'
[patent_app_type] => utility
[patent_app_number] => 09/936333
[patent_app_country] => US
[patent_app_date] => 2000-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 17
[patent_no_of_words] => 28203
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/355/07355015.pdf
[firstpage_image] =>[orig_patent_app_number] => 09936333
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/936333 | Matriptase, a serine protease and its applications | Mar 9, 2000 | Issued |
| 09/515276 | Methods for treating diabetes mellitus | Feb 28, 2000 | Abandoned |
Array
(
[id] => 766730
[patent_doc_number] => 07009044
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-03-07
[patent_title] => 'HCV/BVDV chimeric genomes and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/009011
[patent_app_country] => US
[patent_app_date] => 2000-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 9396
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/009/07009044.pdf
[firstpage_image] =>[orig_patent_app_number] => 10009011
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/009011 | HCV/BVDV chimeric genomes and uses thereof | Feb 5, 2000 | Issued |
Array
(
[id] => 951454
[patent_doc_number] => 06960659
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-11-01
[patent_title] => 'Mosaic protein and restriction endonuclease assisted ligation method for making the same'
[patent_app_type] => utility
[patent_app_number] => 09/491146
[patent_app_country] => US
[patent_app_date] => 2000-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 29
[patent_no_of_words] => 9511
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/960/06960659.pdf
[firstpage_image] =>[orig_patent_app_number] => 09491146
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/491146 | Mosaic protein and restriction endonuclease assisted ligation method for making the same | Jan 24, 2000 | Issued |
Array
(
[id] => 1317585
[patent_doc_number] => 06608183
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-08-19
[patent_title] => 'Derivatives of growth hormone and related proteins'
[patent_app_type] => B1
[patent_app_number] => 09/462941
[patent_app_country] => US
[patent_app_date] => 2000-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32270
[patent_no_of_claims] => 87
[patent_no_of_ind_claims] => 31
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/608/06608183.pdf
[firstpage_image] =>[orig_patent_app_number] => 09462941
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/462941 | Derivatives of growth hormone and related proteins | Jan 13, 2000 | Issued |
Array
(
[id] => 6778520
[patent_doc_number] => 20030049601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-13
[patent_title] => 'METHODS AND COMPOSITIONS FOR DETECTING HEPATITIS E VIRUS'
[patent_app_type] => new
[patent_app_number] => 09/468147
[patent_app_country] => US
[patent_app_date] => 1999-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 41667
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20030049601.pdf
[firstpage_image] =>[orig_patent_app_number] => 09468147
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/468147 | METHODS AND COMPOSITIONS FOR DETECTING HEPATITIS E VIRUS | Dec 20, 1999 | Abandoned |
Array
(
[id] => 740762
[patent_doc_number] => 07029905
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-04-18
[patent_title] => 'Method for the cellular high-throughput-detection of receptor ligand interactions'
[patent_app_type] => utility
[patent_app_number] => 09/869709
[patent_app_country] => US
[patent_app_date] => 1999-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 23889
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/029/07029905.pdf
[firstpage_image] =>[orig_patent_app_number] => 09869709
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/869709 | Method for the cellular high-throughput-detection of receptor ligand interactions | Dec 19, 1999 | Issued |
Array
(
[id] => 538619
[patent_doc_number] => 07169395
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-01-30
[patent_title] => 'Multivalent immunogenic composition containing RSV subunit composition and influenza virus preparation'
[patent_app_type] => utility
[patent_app_number] => 09/868177
[patent_app_country] => US
[patent_app_date] => 1999-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 7633
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 234
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/169/07169395.pdf
[firstpage_image] =>[orig_patent_app_number] => 09868177
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/868177 | Multivalent immunogenic composition containing RSV subunit composition and influenza virus preparation | Dec 15, 1999 | Issued |
| 09/380693 | DNA ENCODING PNEUMOCYSTIS CARINII PROTEASE | Nov 28, 1999 | Abandoned |
| 09/444221 | PRODUCTION OF ATTENUATED RESPIRATORY SYNCYTIAL VIRUS VACCINES FROM CLONED NUCLEOTIDE SEQUENCES | Nov 18, 1999 | Abandoned |
| 09/444067 | PRODUCTION OF ATTENUATED RESPIRATORY SYNCYTIAL VIRUS VACCINES FROM CLONED NUCLEOTIDE SEQUENCES | Nov 18, 1999 | Abandoned |
Array
(
[id] => 1331380
[patent_doc_number] => 06596496
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-22
[patent_title] => 'Analytical system based upon spore germination'
[patent_app_type] => B1
[patent_app_number] => 09/441531
[patent_app_country] => US
[patent_app_date] => 1999-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7782
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 168
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/596/06596496.pdf
[firstpage_image] =>[orig_patent_app_number] => 09441531
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/441531 | Analytical system based upon spore germination | Nov 15, 1999 | Issued |
Array
(
[id] => 875423
[patent_doc_number] => 07357936
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2008-04-15
[patent_title] => 'Adjuvant systems and vaccines'
[patent_app_type] => utility
[patent_app_number] => 09/807657
[patent_app_country] => US
[patent_app_date] => 1999-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8796
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/357/07357936.pdf
[firstpage_image] =>[orig_patent_app_number] => 09807657
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/807657 | Adjuvant systems and vaccines | Oct 7, 1999 | Issued |
Array
(
[id] => 6438498
[patent_doc_number] => 20020128174
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-12
[patent_title] => 'VP22 PROTEINS AND USES THEREOF'
[patent_app_type] => new
[patent_app_number] => 09/381211
[patent_app_country] => US
[patent_app_date] => 1999-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6065
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20020128174.pdf
[firstpage_image] =>[orig_patent_app_number] => 09381211
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/381211 | VP22 PROTEINS AND USES THEREOF | Sep 16, 1999 | Abandoned |
Array
(
[id] => 1085404
[patent_doc_number] => 06830748
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-12-14
[patent_title] => 'Recombinant RSV virus expression systems and vaccines'
[patent_app_type] => B1
[patent_app_number] => 09/368076
[patent_app_country] => US
[patent_app_date] => 1999-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 41980
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/830/06830748.pdf
[firstpage_image] =>[orig_patent_app_number] => 09368076
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/368076 | Recombinant RSV virus expression systems and vaccines | Aug 2, 1999 | Issued |
Array
(
[id] => 925607
[patent_doc_number] => 07316905
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2008-01-08
[patent_title] => 'Method for measurement of hepatitis C virus'
[patent_app_type] => utility
[patent_app_number] => 09/509449
[patent_app_country] => US
[patent_app_date] => 1999-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10096
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 236
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/316/07316905.pdf
[firstpage_image] =>[orig_patent_app_number] => 09509449
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/509449 | Method for measurement of hepatitis C virus | Jul 29, 1999 | Issued |
Array
(
[id] => 1024092
[patent_doc_number] => 06884435
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-04-26
[patent_title] => 'Microparticles with adsorbent surfaces, methods of making same, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 09/581772
[patent_app_country] => US
[patent_app_date] => 1999-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14773
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/884/06884435.pdf
[firstpage_image] =>[orig_patent_app_number] => 09581772
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/581772 | Microparticles with adsorbent surfaces, methods of making same, and uses thereof | Jul 28, 1999 | Issued |
| 09/331713 | ANNEXIN V-BINDING POLYPEPTIDES DERIVED FROM HBSAG AND THEIR USES | Jun 24, 1999 | Abandoned |